Author:
Chen Steven T.,Molina Gabriel E.,Lo Jennifer A.,Durbin Sienna,Cohen Justine V.,Reynolds Kerry L.,Kroshinsky Daniela
Reference5 articles.
1. Dermatologic adverse events of checkpoint inhibitors: what an oncologist should know;Habre;Immunotherapy,2016
2. Immune-related adverse events requiring inpatient management: spectrum of toxicity, treatment, and outcomes;Balaji,2018
3. Inpatient admissions related to immune-related adverse effects (irAE) among patients treated with immune checkpoint inhibitors for advanced malignancy: a tsunami is coming, but are we ready?;Reynolds,2018
4. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline;Brahmer;J Clin Oncol,2018
5. High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma;Faje;Cancer,2018
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献